Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non–Small-Cell Lung Cancer

Published:2018-01 Issue:1 Volume:19 Page:58-64
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Woodard Gavitt A.^ORCID,Wang Sue X.,Kratz Johannes R.,Zoon-Besselink Clara T.,Chiang Chun-Yuan,Gubens Matthew A.,Jahan Thierry M.,Blakely Collin M.,Jones Kirk D.,Mann Michael J.^ORCID,Jablons David M.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference11 articles.

1. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Groome;J Thorac Oncol,2007

2. Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer;Winton;N Engl J Med,2005

3. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non–small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

4. Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer;Arriagada;N Engl J Med,2004

5. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of ctDNA in early diagnosis, treatment and prognosis of patients with non-small cell lung cancer;Future Oncology;2024-07-29

2. Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center;Frontiers in Oncology;2024-03-11

3. Genomic profiling and metastatic risk in early-stage non–small cell lung cancer;JTCVS Open;2023-12

4. Genomic profiling for non-small cell lung cancer: Clinical relevance in staging and prognosis;Medicine;2023-11-24

5. The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations;eClinicalMedicine;2023-10